Equities
  • Price (EUR)62.62
  • Today's Change-0.84 / -1.32%
  • Shares traded0.00
  • 1 Year change+5.28%
  • Beta0.8217
Data delayed at least 15 minutes, as of Jul 04 2025.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Henry Schein, Inc. is a solutions company for healthcare professionals. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.

  • Revenue in USD (TTM)12.67bn
  • Net income in USD407.00m
  • Incorporated1992
  • Employees25.00k
  • Location
    Henry Schein Inc135 Duryea RdMELVILLE 11747United StatesUSA
  • Phone+1 (631) 843-5500
  • Fax+1 (302) 636-5454
  • Websitehttps://www.henryschein.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
HSIC:NSQ since
announced
Transaction
value
Acentus LLCDeal completed20 Nov 202420 Nov 2024Deal completed-0.23%--
ABC Dental AGDeal completed29 Jul 202429 Jul 2024Deal completed3.26%--
Data delayed at least 15 minutes, as of Jul 03 2025 18:00 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.